Immunogenicity of hepatitis A-inactivated vaccine administered to seronegative infants, and serological follow-up 12 months after second dose

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 12, 2006, Pages 1582-1585

  De Silvestri, Annalisa ^a   Zara, Francesca ^b   Terulla, Virginio ^a   Brerra, Roberto ^b   Zucca, Silvana ^a   Belloni, Cesare ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Anti HAV vaccine; Immunization; Infants

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA;

ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEPATITIS A; HUMAN; IMMUNIZATION; INFANT; INFANT DISEASE; INJECTION SITE ERYTHEMA; MAJOR CLINICAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; VACCINATION; VIRUS HEPATITIS;

EVALUATION STUDIES; FOLLOW-UP STUDIES; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT;

EID: 33845260084     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250600615119     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendation of the Advisory Committee on Immunization Practice (ACIP) MMWR 1999;48:1-38.
2. Bell BP, Shapiro CN, Alter MJ, Moyer LA, Judson FN, Mottram K, et al. The diverse patterns of hepatitis A epidemiology in the United States - implications for vaccination strategies. J Infect Dis 1998;178:1579-84.
3. Bell BP, Feinstone SM. Hepatitis A vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. th ed. Philadelphia: Saunders; 2004. p. 269-97.
4. Mele A, Stroffolini T, Palumbo F, Gallo G, Ragni P, Balocchini E, et al. Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. SEIEVA Collaborating Group. J Hepatol 1997;26:743-7.
5. Abarca K, Ibanez I, Flores J, Vial PA, Safary A, Potin M. Vaccination against hepatitis A in children aged 12 to 24 months [corrected]. Arch Med Res 2001;32:468-72. Erratum in: Arch Med Res 2002;33:205.
6. Piazza M, Safary A, Vegnente A, Soncini R, Pensati P, Sardo M, et al. Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine 1999;17:585-8.
7. Dagan R, Amir J, Mijalovsky A, Kalmanovitch I, Bar-Yochai A, Thoelen S, et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr Infect Dis J 2000;19:1045-52.
8. Letson GW, Shapiro CN, Kuehn D, Gardea C, Welty TK, Krause DS, et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. J Pediatr 2004;144:327-32.
9. Fiore AE, Shapiro CN, Sabin K, Labonte K, Darling K, Culver D, et al. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose. Pediatr Infect Dis J 2003;22:354-9.
10. De Silvestri A, Avanzini MA, Terulla V, Zucca S, Polatti F, Belloni C. Decline of maternal hepatitis A virus antibody levels in infants. Acta Paediatr 2002;91:882-4.
11. Maiwald H, Jilg W, Bock HL, Loscher T, Sonnenburg F. Long-term persistence of anti-HAVantibodies following active immunization with hepatitis A vaccine. Vaccine 1997;15:346-8.
12. Van Herck K, Beutels P, Van Damme P, Beutels M, Van den Dries J, Briantais P, et al. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines. J Med Virol 2000;60:1-7.
13. Zaaijer HL, Leentvaar-Kuijpers A, Rotman H, Lelie PN. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization. J Med Virol 1993;40:22-7.
14. Polish LB, Robertson BH, Khanna B, Krawczynski K, Spelbring J, Olson F, et al. Excretion of hepatitis A virus (HAV) in adults: comparison of immunologic and molecular detection methods and relationship between HAV positivity and infectivity in tamarins. J Clin Microbiol 1999;37:3615-7.
15. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
16. Cohen JI, Rosenblum B, Ticehurst JR, Daemer RJ, Feinstone SM, Purcell RH. Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A 1987;84:2497-501.
17. Pina S, Buti M, Jardi R, Clemente-Casares P, Jofre J, Girones R. Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis. J Gen Virol 2001;82:2955-63.
18. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J 1993;12:359-62.
19. Lopez EL, Del Carmen Xifro M, Torrado LE, De Rosa MF, Gomez R, Dumas R, et al. Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children. Pediatr Infect Dis J 2001;20:48-52.
20. Belloni C, Tinelli C, Orsolini P, Pistorio A, Avanzini A, Moretta A, et al. Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. Vaccine 1998;16:399-402.
21. Van Herck K, Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 2001;63:1-7.
22. Fan PC, Chang MH, Lee PI, Safary A, Lee CY. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years. Vaccine 1998;16:232-5.
23. Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinatnts. Vaccine 2003;21:3406-12.
24. Craig AS, Schaffner W. Clinical practice. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004;350:476-81.